These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 37734206)
1. Efficacy of metformin targets on cardiometabolic health in the general population and non-diabetic individuals: a Mendelian randomization study. Zheng J; Xu M; Yang Q; Hu C; Walker V; Lu J; Wang J; Liu R; Xu Y; Wang T; Zhao Z; Yuan J; Burgess S; Au Yeung SL; Luo S; Anderson EL; Holmes MV; Smith GD; Ning G; Wang W; Gaunt TR; Bi Y EBioMedicine; 2023 Oct; 96():104803. PubMed ID: 37734206 [TBL] [Abstract][Full Text] [Related]
2. The effect of metformin on urate metabolism: Findings from observational and Mendelian randomization analyses. Dai H; Hou T; Wang Q; Zhu Z; Zhu Y; Zhao Z; Li M; Xu Y; Lu J; Wang T; Ning G; Wang W; Bi Y; Zheng J; Xu M Diabetes Obes Metab; 2024 Jan; 26(1):242-250. PubMed ID: 37807832 [TBL] [Abstract][Full Text] [Related]
3. Drug-target Mendelian randomization revealed a significant association of genetically proxied metformin effects with increased prostate cancer risk. Sun X; Ping J; Guo X; Long J; Cai Q; Shu XO; Shu X Mol Carcinog; 2024 May; 63(5):849-858. PubMed ID: 38517045 [TBL] [Abstract][Full Text] [Related]
4. Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer's disease risk in the general population: a Mendelian randomisation study. Zheng J; Xu M; Walker V; Yuan J; Korologou-Linden R; Robinson J; Huang P; Burgess S; Au Yeung SL; Luo S; Holmes MV; Davey Smith G; Ning G; Wang W; Gaunt TR; Bi Y Diabetologia; 2022 Oct; 65(10):1664-1675. PubMed ID: 35902387 [TBL] [Abstract][Full Text] [Related]
5. The Causal Effect of Systolic Blood Pressure Lowering on Vascular Outcomes in Diabetes: A Mendelian Randomization Study. Hou T; Li M; Lin H; Zhao Z; Lu J; Wang T; Xu Y; Wang W; Bi Y; Ning G; Xu M J Clin Endocrinol Metab; 2022 Aug; 107(9):2616-2625. PubMed ID: 35703944 [TBL] [Abstract][Full Text] [Related]
6. Effects of body mass index and blood pressure on atrioventricular block: Two-sample mendelian randomization. Chi X; Zhang N; Zhang L; Fan F; Jia J; Xu M; Li J Heart Rhythm; 2024 Feb; 21(2):174-183. PubMed ID: 37918507 [TBL] [Abstract][Full Text] [Related]
7. Genetically Proxied Therapeutic Effect of Metformin Use, Blood Pressure, and Hypertension's Risk: a Drug Target-Based Mendelian Randomization Study. Jiang J; Hu D; Zhang Q; Lin Z; J Cardiovasc Transl Res; 2024 Jun; 17(3):716-722. PubMed ID: 38012470 [TBL] [Abstract][Full Text] [Related]
8. Association of Body Mass Index With Cardiometabolic Disease in the UK Biobank: A Mendelian Randomization Study. Lyall DM; Celis-Morales C; Ward J; Iliodromiti S; Anderson JJ; Gill JMR; Smith DJ; Ntuk UE; Mackay DF; Holmes MV; Sattar N; Pell JP JAMA Cardiol; 2017 Aug; 2(8):882-889. PubMed ID: 28678979 [TBL] [Abstract][Full Text] [Related]
9. Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis. Yarmolinsky J; Díez-Obrero V; Richardson TG; Pigeyre M; Sjaarda J; Paré G; Walker VM; Vincent EE; Tan VY; Obón-Santacana M; Albanes D; Hampe J; Gsur A; Hampel H; Pai RK; Jenkins M; Gallinger S; Casey G; Zheng W; Amos CI; ; ; ; Smith GD; Martin RM; Moreno V PLoS Med; 2022 Feb; 19(2):e1003897. PubMed ID: 35113855 [TBL] [Abstract][Full Text] [Related]
10. Negative Effects of Age at Menarche on Risk of Cardiometabolic Diseases in Adulthood: A Mendelian Randomization Study. Cao M; Cui B J Clin Endocrinol Metab; 2020 Feb; 105(2):. PubMed ID: 31614369 [TBL] [Abstract][Full Text] [Related]
11. Evaluating the impact of metformin targets on the risk of osteoarthritis: a mendelian randomization study. Zhang Y; Li D; Zhu Z; Chen S; Lu M; Cao P; Chen T; Li S; Xue S; Zhang Y; Zhu J; Ruan G; Ding C Osteoarthritis Cartilage; 2022 Nov; 30(11):1506-1514. PubMed ID: 35803489 [TBL] [Abstract][Full Text] [Related]
12. Impact of glycemic traits, type 2 diabetes and metformin use on breast and prostate cancer risk: a Mendelian randomization study. Au Yeung SL; Schooling CM BMJ Open Diabetes Res Care; 2019; 7(1):e000872. PubMed ID: 31908803 [TBL] [Abstract][Full Text] [Related]
13. The Associations of Genetically Predicted Plasma Alanine with Coronary Artery Disease and its Risk Factors: A Mendelian Randomization Study. Huang X; Zhao JV Am J Clin Nutr; 2023 Nov; 118(5):1020-1028. PubMed ID: 37640107 [TBL] [Abstract][Full Text] [Related]
14. The Impact of Glycated Hemoglobin (HbA Au Yeung SL; Luo S; Schooling CM Diabetes Care; 2018 Sep; 41(9):1991-1997. PubMed ID: 29950300 [TBL] [Abstract][Full Text] [Related]
15. The impact of homocysteine on the risk of coronary artery diseases in individuals with diabetes: a Mendelian randomization study. Xu T; Chen S; Yang F; Wang Y; Zhang K; Fu G; Zhang W Acta Diabetol; 2021 Mar; 58(3):301-307. PubMed ID: 33113028 [TBL] [Abstract][Full Text] [Related]
16. TNF inhibitors associated with cardiovascular diseases and cardiometabolic risk factors: a Mendelian randomization study. Liu ZY; Huang XB; Yang GM; Zhao S Eur Rev Med Pharmacol Sci; 2023 Sep; 27(18):8556-8578. PubMed ID: 37782172 [TBL] [Abstract][Full Text] [Related]
17. Cardiometabolic traits mediating the effect of education on osteoarthritis risk: a Mendelian randomization study. Gill D; Karhunen V; Malik R; Dichgans M; Sofat N Osteoarthritis Cartilage; 2021 Mar; 29(3):365-371. PubMed ID: 33422704 [TBL] [Abstract][Full Text] [Related]
18. The impact of age-specific childhood body-mass index on adult cardiometabolic traits: a Mendelian randomization study. Yang J; Kuang Y; Yang X; Li C; Qi M; Fu P; Zeng X Front Endocrinol (Lausanne); 2023; 14():1159547. PubMed ID: 38288476 [TBL] [Abstract][Full Text] [Related]
19. Genetically Predicted Type 2 Diabetes Mellitus Liability, Glycated Hemoglobin and Cardiovascular Diseases: A Wide-Angled Mendelian Randomization Study. Liu B; Mason AM; Sun L; Di Angelantonio E; Gill D; Burgess S Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34681038 [TBL] [Abstract][Full Text] [Related]
20. Genetically Higher Level of Mannose Has No Impact on Cardiometabolic Risk Factors: Insight from Mendelian Randomization. Mazidi M; Dehghan A; Banach M; On Behalf Of The Lipid And Blood Pressure Meta-Analysis Collaboration Lbpmc Group And The International Lipid Expert Panel Ilep Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444725 [No Abstract] [Full Text] [Related] [Next] [New Search]